About Us
AmacaThera is at the forefront of transforming drug delivery through its clinically validated hydrogel drug delivery platform, designed to ensure precise, localized, and sustained release of a diverse array of therapeutics.
Company
Headquartered in Toronto, Canada, AmacaThera emerged in 2016 as a spin-out from The Shoichet Lab, founded by Dr. Mike Cooke and Dr. Molly Shoichet, with the backing of Toronto's vibrant early-stage biotechnology community. Our clinically validated hydrogel drug delivery platform is designed to ensure precise, localized, and sustained release of a diverse array of therapeutics, transforming the way medicines are delivered to patients.
Our Team
AmacaThera's leadership team brings together expertise in business, science, and engineering to transform drug delivery
Senior Management Team
Dr. Mike Cooke
Co-Founder & CEO
Dr. Molly Shoichet
Co-Founder & Chief Science Officer
Andrew Bishop
Chief Financial Officer
Abhaya Khulbe CFA
Chief of Staff & Materials Engineer
Scientific Team
The AmacaThera scientific team driving next-generation therapeutics
Timothy Cheung
Scientist
Kevin Wai
Scientist
Elaine Reguera
Senior Scientist
Lee Ann Girgotti
Scientist
Neil Jurkiewiecz
Scientist
Nazli Hassnepou
Scientist
Board of Directors
AmacaThera is led by a seasoned board providing strategic oversight to advance hydrogel drug delivery
Gael Mourant
Peter van der Velden
Dr. Eyal S Ron
Dr. Molly Shoichet
Dr. Mike Cooke
Gillian Stacey
Collaborations and Partnering
Partnering to elevate therapeutics with localized, controlled delivery
AmacaThera believes partnerships are essential to unlocking the full potential of innovative therapeutics. The Company's transformative hydrogel drug delivery platform provides precise, localized, and sustained drug delivery in an easy-to-administer format across a wide range of therapeutic areas.
AmacaThera collaborates with pharmaceutical companies to enhance existing and emerging drug candidates, combining its proprietary hydrogel platform with next-generation therapeutics to accelerate development timelines and expand therapeutic potential.
By providing flexible, tunable release profiles and a scalable manufacturing process, AmacaThera enables partners to bring transformative therapies to patients worldwide with reduced risk and greater efficiency.
For partnership enquiries and opportunities with AmacaThera, reach out to us at
[email protected]